BAFNA PHARMACEUTICALS
|
BAFNA PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr | ₹44 Cr |
Sales | ₹114 Cr | ₹82 Cr | ₹67 Cr | ₹41 Cr | ₹43 Cr |
Job Work/ Contract Receipts | ₹1.30 Cr | ₹3.39 Cr | ₹3.06 Cr | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | ₹0.88 Cr | ₹1.08 Cr | ₹0.27 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr | ₹44 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-2.91 Cr | ₹-1.77 Cr | ₹2.95 Cr | ₹-3.24 Cr | ₹0.81 Cr |
Raw Material Consumed | ₹66 Cr | ₹42 Cr | ₹29 Cr | ₹19 Cr | ₹23 Cr |
Opening Raw Materials | ₹9.77 Cr | ₹9.82 Cr | ₹4.43 Cr | ₹2.92 Cr | ₹3.23 Cr |
Purchases Raw Materials | ₹63 Cr | ₹42 Cr | ₹34 Cr | ₹21 Cr | ₹22 Cr |
Closing Raw Materials | ₹13 Cr | ₹9.77 Cr | ₹9.82 Cr | ₹4.43 Cr | ₹2.92 Cr |
Other Direct Purchases / Brought in cost | ₹6.41 Cr | - | - | ₹0.02 Cr | ₹0.46 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹5.31 Cr | ₹3.93 Cr | ₹2.95 Cr | ₹2.69 Cr | ₹2.50 Cr |
Electricity & Power | ₹5.31 Cr | ₹3.93 Cr | ₹2.95 Cr | ₹2.69 Cr | ₹2.50 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹16 Cr | ₹15 Cr | ₹12 Cr | ₹10 Cr | ₹9.01 Cr |
Salaries, Wages & Bonus | ₹14 Cr | ₹13 Cr | ₹9.43 Cr | ₹9.14 Cr | ₹8.13 Cr |
Contributions to EPF & Pension Funds | ₹1.13 Cr | ₹1.35 Cr | ₹0.52 Cr | ₹0.56 Cr | ₹0.58 Cr |
Workmen and Staff Welfare Expenses | ₹0.59 Cr | ₹0.55 Cr | ₹1.72 Cr | ₹0.55 Cr | ₹0.31 Cr |
Other Employees Cost | - | - | ₹0.31 Cr | - | - |
Other Manufacturing Expenses | ₹8.78 Cr | ₹8.69 Cr | ₹11 Cr | ₹8.55 Cr | ₹8.16 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹2.51 Cr | ₹1.95 Cr | ₹2.01 Cr | ₹1.76 Cr | ₹1.29 Cr |
Packing Material Consumed | - | - | ₹4.78 Cr | ₹3.81 Cr | ₹3.87 Cr |
Other Mfg Exp | ₹6.27 Cr | ₹6.74 Cr | ₹3.87 Cr | ₹2.98 Cr | ₹3.01 Cr |
General and Administration Expenses | ₹3.18 Cr | ₹3.10 Cr | ₹2.87 Cr | ₹3.05 Cr | ₹2.50 Cr |
Rent , Rates & Taxes | ₹0.31 Cr | ₹0.20 Cr | ₹0.21 Cr | ₹0.27 Cr | ₹0.32 Cr |
Insurance | ₹0.17 Cr | ₹0.17 Cr | ₹0.16 Cr | ₹0.09 Cr | ₹0.01 Cr |
Printing and stationery | ₹0.20 Cr | ₹0.17 Cr | ₹0.26 Cr | ₹0.17 Cr | ₹0.16 Cr |
Professional and legal fees | ₹1.09 Cr | ₹1.65 Cr | ₹1.06 Cr | ₹1.42 Cr | ₹1.02 Cr |
Traveling and conveyance | ₹0.53 Cr | ₹0.20 Cr | ₹0.15 Cr | ₹0.28 Cr | ₹0.26 Cr |
Other Administration | ₹0.88 Cr | ₹0.71 Cr | ₹1.04 Cr | ₹0.83 Cr | ₹0.73 Cr |
Selling and Distribution Expenses | ₹2.11 Cr | ₹2.87 Cr | ₹0.65 Cr | ₹0.41 Cr | ₹0.81 Cr |
Advertisement & Sales Promotion | ₹0.56 Cr | ₹0.59 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.06 Cr |
Sales Commissions & Incentives | - | ₹0.04 Cr | - | ₹0.04 Cr | - |
Freight and Forwarding | ₹1.55 Cr | ₹2.25 Cr | ₹0.59 Cr | ₹0.31 Cr | ₹0.75 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | ₹0.00 Cr |
Miscellaneous Expenses | ₹1.33 Cr | ₹0.06 Cr | ₹0.08 Cr | ₹0.12 Cr | ₹9.77 Cr |
Bad debts /advances written off | ₹0.30 Cr | - | - | - | ₹9.48 Cr |
Provision for doubtful debts | ₹0.37 Cr | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | ₹0.04 Cr | ₹0.06 Cr | ₹0.09 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.66 Cr | ₹0.06 Cr | ₹0.04 Cr | ₹0.07 Cr | ₹0.21 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹100 Cr | ₹73 Cr | ₹61 Cr | ₹41 Cr | ₹57 Cr |
Operating Profit (Excl OI) | ₹16 Cr | ₹12 Cr | ₹10 Cr | ₹1.23 Cr | ₹-13 Cr |
Other Income | ₹3.27 Cr | ₹1.76 Cr | ₹0.75 Cr | ₹0.26 Cr | ₹0.39 Cr |
Interest Received | ₹0.05 Cr | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.12 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.20 Cr | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | ₹0.28 Cr | - | - |
Foreign Exchange Gains | ₹1.48 Cr | ₹0.36 Cr | ₹0.42 Cr | ₹0.21 Cr | ₹0.09 Cr |
Others | ₹1.55 Cr | ₹1.36 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.18 Cr |
Operating Profit | ₹19 Cr | ₹14 Cr | ₹11 Cr | ₹1.48 Cr | ₹-13 Cr |
Interest | ₹2.04 Cr | ₹0.79 Cr | ₹0.74 Cr | ₹0.10 Cr | ₹2.13 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹1.80 Cr | ₹0.52 Cr | - | - | ₹1.97 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.24 Cr | ₹0.27 Cr | ₹0.65 Cr | ₹0.10 Cr | ₹0.16 Cr |
Other Interest | - | - | ₹0.09 Cr | ₹0.00 Cr | - |
PBDT | ₹17 Cr | ₹13 Cr | ₹10 Cr | ₹1.39 Cr | ₹-15 Cr |
Depreciation | ₹5.33 Cr | ₹5.49 Cr | ₹4.48 Cr | ₹3.27 Cr | ₹3.42 Cr |
Profit Before Taxation & Exceptional Items | ₹12 Cr | ₹7.37 Cr | ₹5.83 Cr | ₹-1.88 Cr | ₹-18 Cr |
Exceptional Income / Expenses | - | ₹-2.16 Cr | - | - | - |
Profit Before Tax | ₹12 Cr | ₹5.22 Cr | ₹5.83 Cr | ₹-1.88 Cr | ₹-18 Cr |
Provision for Tax | ₹0.28 Cr | - | - | - | ₹1.50 Cr |
Current Income Tax | - | - | - | - | - |
Deferred Tax | - | - | - | - | ₹1.50 Cr |
Other taxes | ₹0.28 Cr | - | - | - | - |
Profit After Tax | ₹11 Cr | ₹5.22 Cr | ₹5.83 Cr | ₹-1.88 Cr | ₹-20 Cr |
Extra items | - | - | - | ₹-23 Cr | - |
Adjustments to PAT | - | - | ₹0.00 Cr | - | - |
Profit Balance B/F | ₹-66 Cr | ₹-71 Cr | ₹-77 Cr | ₹-52 Cr | ₹-32 Cr |
Appropriations | ₹-55 Cr | ₹-66 Cr | ₹-71 Cr | ₹-77 Cr | ₹-52 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹-0.15 Cr | ₹0.02 Cr | - | - | - |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹4.79 | ₹2.21 | ₹2.46 | ₹-7.94 | ₹-8.34 |
Adjusted EPS | ₹4.79 | ₹2.21 | ₹2.46 | ₹-7.94 | ₹-8.34 |
Compare Income Statement of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹192.0 Cr | 1.3% | 1.3% | -8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 1.3% |
1.3% |
-8.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses